ARCHIVES

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

This article is from The Cancer Letter archive.

Vol. 18 No. 21 | May 22, 1992

Download PDF Visit The Full Archive

Related Articles

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995

Abstracts Of Papers From Gynecologic Oncology Conference

October 17, 1975

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

November 5, 1982

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012